Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail
-

Public Calendar: February 2-6, 2009

 

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

FDA Official and Title Date Location Other FDA Participants Non-FDA Participants Subject
Frank Torti, Acting Commissioner 2/2/2009 San Francisco, CA Pam Pisner David Parkinson, (Nodality) Meeting with Nodality Senior staff regarding FDA Science Board Activities 
Frank Torti, Acting Commissioner 2/3/2009 San Francisco, CA Pam Pisner Art Levinson, Sue Hellman, Mary Silwkowski, Pat Yang, Todd Rich, Hal Barron, Cathy Hollenbach (Genentech) Meeting regarding  biotech industry issues
Frank Torti, Acting Commissioner 2/3/2009 San Francisco, CA Pam Pisner David Kessler (University of Southern California) FDA  management issues
John Dyer, Deputy Commissioner for Operations and Chief Operating Officer 2/2/09 through 2/6/09 N/A N/A N/A No significant meetings
Murray Lumpkin, Deputy Commissioner for International and Special Programs 2/2/09 through 2/4/09 Basel, Switzerland N/A N/A Session Chair and Lectured at the University of Basel's 2009 European Center of Pharmaceutical Course
Randall Lutter, Deputy Commissioner for Policy 2/2/09 through 2/6/09 N/A N/A N/A No significant meetings
Janet Woodcock, Director, Center for Drug Evaluation and Research 2/4/2009 Silver Spring, Maryland Rachel Behrman, Melissa Robb Ray Woosley,MD, Mark McClellan, MD Coalition Against Major Diseases Meeting
Janet Woodcock, Director, Center for Drug Evaluation and Research 2/4/2009 Washington, DC Rachel Behrman, MD,  Thomas Scarnecchia, FNIH Observational Medical Outcomes Partnership, Executive Board Meeting
Janet Woodcock, Director, Center for Drug Evaluation and Research 2/5/2009 Bethesda, MD N/A N/A Principles of Clinical Pharmacology Lecture
Michael Chappell, Acting Associate Commissioner, Office of Regulatory Affairs 2/2/09 through 2/6/09 N/A N/A N/A No significant meetings
Jesse Goodman, Director, Center for Biologics Evaluation and Research 02/03-04/09 Washington, D.C. N/A N/A Government Liaison Group of the National Academies Standing Committee on Use of Emerging Science for Environmental Health Decisions
Daniel Schultz, Director, Center for Devices and Radiological Health 2/6/2009 Bethesda MD N/A N/A International Society for Computerized Electrocardiology (ISCE) conference
Stephen Sundlof, Center for Food Safety and Applied Nutrition 2/2/09 through 2/6/09 N/A N/A N/A No significant meetings
Bernadette Dunham, Director, Center for Veterinary Medicine 2/2/09 through 2/6/09 N/A N/A N/A No significant meetings
William Slikker, Director, National Center for Toxicological Research 2/3-4/09 Washington, D.C. N/A N/A Government Liaison Group of the National Academies Standing Committee on Use of Emerging Science for Environmental Health Decisions
Jeffrey M. Senger, Acting Chief Counsel 2/2/09 through 2/6/09 N/A N/A N/A No significant meetings

 

-
-